Skip to main content

Published locations for Abrocitinib remains effective at 96 weeks, in older as well as younger adults

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Abrocitinib remains effective at 96 weeks, in older as well as younger adults

User login

  • Reset your password
  • /content/abrocitinib-remains-effective-96-weeks-older-well-younger-adults
  • /clinicianreviews/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older-well
  • /edermatologynews/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older-well
  • /familypracticenews/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older
  • /fedprac/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older-well-younger
  • /internalmedicinenews/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older
  • /internalmedicine/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older-well
  • /dermatology/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older-well
  • /familymedicine/article/263374/atopic-dermatitis/abrocitinib-remains-effective-96-weeks-older-well